2-Bromo-5-(methoxymethyl)aniline, 95.0%, 1g

Methyl 4-(aminomethyl)benzoate hydrochloride, 95.0%, 1g

2-(4-Methoxyphenyl)-5-methyl-1,3,4-oxadiazole, 250mg

3,4-Dihydro-2H-benzo[b][1,4,5]oxathiazepine 1,1-dioxide, 98%, 1g

Ethyl 2-Cyanobenzoate, 97.0%, 100g

3-Bromo-4-hydroxybenzaldehyde, 95.0%, 500g

Cyclopropanecarboxamide, 95.0%, 10g

Periodato di sodio, minimo 99,8%, pa, ACS, 50 g, confezione in plastica.

(S)-3-(1-(tert-Butoxycarbonyl)-1H-imidazol-4-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 5g

2,6-Difluoro-3-phenylbenzaldehyde, 98%, 500mg

1,3-Diphenyl-2-propanone>97.0%(GC)100g

2-Hydrazinyl-5-methylpyridine, 95.0%, 5g

4-(4-methoxyphenoxy)benzoic acid, 95.0%, 250mg